Cargando…
Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone
Delafloxacin is a novel fluoroquinolone agent that is approved for clinical application. In this study, we analyzed the antibacterial efficacy of delafloxacin in a collection of 47 Escherichia coli strains. Antimicrobial susceptibility testing was performed by the broth microdilution method and mini...
Autores principales: | Gulyás, Dániel, Kamotsay, Katalin, Szabó, Dóra, Kocsis, Béla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301206/ https://www.ncbi.nlm.nih.gov/pubmed/37375104 http://dx.doi.org/10.3390/microorganisms11061602 |
Ejemplares similares
-
Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli
por: Kocsis, Béla, et al.
Publicado: (2022) -
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021) -
Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones
por: Kocsis, Béla, et al.
Publicado: (2021) -
Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone
por: Schembri, Mark A., et al.
Publicado: (2015) -
Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital
por: Tóth, Kinga, et al.
Publicado: (2022)